Nurse Practitioner, Family · Plantation, FL
NPI
1104425669
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4302 W Broward Blvd
Plantation, FL, 33317
Phone (954) 644-8902
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$442K
6,538 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alina Poll prescribed most often to Medicare patients was Atorvastatin Calcium, with 549 prescriptions and refills. In total Alina Poll wrote 6,538 Medicare prescriptions that cost $442K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 549 | 1,584 | 221 | $8,080 |
| Amlodipine Besylate Generic | 392 | 1,119 | 162 | $4,206 |
| Metformin Hcl Generic | 294 | 812 | 112 | $3,142 |
| Baclofen Generic | 290 | 317 | 133 | $1,928 |
| Gabapentin Generic | 242 | 692 | 103 | $3,231 |
| Lisinopril Generic | 210 | 592 | 88 | $2,649 |
| Omeprazole Generic | 200 | 543 | 84 | $2,574 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 198 | 526 | 104 | $2,408 |
| Folic Acid Generic | 150 | 426 | 67 | $716 |
| Hydrochlorothiazide Generic | 150 | 412 | 63 | $1,400 |
| Glipizide Generic | 137 | 373 | 52 | $1,692 |
| Jardiance Empagliflozin | 127 | 131 | 22 | $77K |
| Losartan Potassium Generic | 126 | 369 | 59 | $1,991 |
| Labetalol Hcl Generic | 118 | 333 | 49 | $4,482 |
| Cyproheptadine Hcl Generic | 113 | 230 | 55 | $2,974 |
Brand drugs: 682 claims; generic drugs: 5,800 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alina Poll were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.